News | Wearables | April 14, 2022

Smartwatch App Found to Accurately Detect Atrial Fibrillation

Technology shows promise for early diagnosis of heart rhythm disorder and sleep apnea

Smart watch heart monitor

Image: Getty Images

April 14, 2022 – Atrial fibrillation (AFib) was confirmed in nearly 94% of people who were initially identified to have signs of the heart rhythm disorder by a smartwatch application and who followed up with a clinician, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

The study, which involved more than 2.8 million participants, is the largest study to date to demonstrate how wearable consumer technologies can be used to screen for heart problems during everyday activities. Researchers also used the app to screen a subset of participants for obstructive sleep apnea and found that people flagged for possible sleep apnea were 1.5 times more likely to have AFib than those who were not. This suggests that tools suitable for detecting the two conditions can work synergistically to further enhance health monitoring.

“Digital technologies make it possible to increase general awareness about AFib and its risk factors as well as to improve prevention of AFib and its complications,” said Yutao Guo, MD, professor of internal medicine at Chinese PLA Medical School and Chinese PLA General Hospital in Beijing and the study’s lead author. “With the global surge of wearable technology for AFib screening, especially in the challenging setting of the COVID-19 pandemic, the present study provides a possible solution to help people identify possible signs of AFib and get diagnosed and treated earlier.”

AFib is the most common type of heart rhythm disorder, with symptoms including a rapid or irregular heartbeat along with episodes of lightheadedness, chest pain and shortness of breath. People with AFib are about five times more likely to suffer a stroke compared with the general population because an erratic heartbeat can cause blood to pool and clot. However, this risk can be lowered with early diagnosis and treatment.

The study, conducted in China, combined data from smart devices with clinical data to examine the accuracy of AFib screening using photoplethysmography, a light-based method to monitor blood flow used in many wearable devices. Researchers tracked more than 2.8 million people who downloaded an AFib screening app on a compatible Huawei smart device (a consumer electronics brand popular in China). The smart device uses photoplethysmography to monitor the wearer’s pulse and the app applies an algorithm to detect when the heart rhythm is abnormal. If an abnormal rhythm was detected, the wearer would be contacted by a clinician to set up an appointment for a clinical assessment.

Over the course of four years (2018-2021), 12,244 users received a notification of suspected AFib. Among 5,227 people who chose to follow up with a clinician, AFib was confirmed in 93.8% of patients using standard AFib diagnostic tools including clinical evaluation, an electrocardiogram and 24-hour Holter monitoring, where someone wears a device to track heart activity while they go about their usual activities including sleeping.

Photoplethysmography can also be used to detect physiological changes that occur when a person has obstructive sleep apnea, a condition that disrupts breathing during sleep. Previous studies have suggested that about half of people with AFib also have sleep apnea. In this study, 961,931 of the app users screened for AFib were also screened for signs of sleep apnea. Of these, about 18,000 were notified they may have the condition. Results also showed a high rate of AFib diagnosis among this group, with 1.5-fold higher odds of receiving an AFib diagnosis among those who were flagged for sleep apnea compared to those who were not.

“This consumer-led AFib screening approach highlights the increased risk for detecting prevalent AFib episodes over time and the need for modification of obstructive sleep apnea and other risk factors that increase AFib susceptibility,” Guo said. “Future studies will be needed to move toward using ‘smart’ technology to help manage AFib and the risk factors that increase AFib susceptibility, as well as to evaluate attitudes and concerns related to this digital health tool.”

While the study used Huawei devices, more common devices in the U.S. such as the Apple Watch or FitBit have similar photoplethysmography technology that can be used to measure a person’s pulse and detect abnormalities.

One limitation of the study is that only 53.3% of those who received a notification of suspected AFib effectively followed up with a clinician for further evaluation. Researchers were unable to verify whether the remaining individuals had clinically confirmed AFib or determine why they did not follow up for a health assessment.

The study was funded by the National Natural Science Foundation of China.

Find more ACC.22 content here

Related Content on Wearables and Big Data in Healthcare:

New Fitbit Feature Makes AFib Detection More Accessible

Tracking Cardiovascular Health Population Trends Using Consumer Wearables

Bristol-Myers Squibb-Pfizer Alliance, Fitbit Team Up on Atrial Fibrillation Detection

Artificial Intelligence Detects AFib Using Apple Watch Heart Rate Sensor

Consumer Smart Watches Accurately Measure Paroxysmal Supraventricular Tachycardia

VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.

VIDEO: Mobile App Links Wearable Data to Electronic Medical Records

Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation

VIDEO: Use of Wearables to Track Electrophysiology Patients — Interview with Khaldoun Tarakji, M.D.

VIDEO: The Future of Wearables in Healthcare — Karl Poterack, M.D.

8 Cardiovascular Technologies to Watch in 2020

VIDEO: Healthcare Technology Advances at CES 2019

Welcoming Apple to the World of ECG

Related Content

News | Wearables

May 18, 2022 — A new app developed by the Mayo Clinic transmits Apple Watch electrocardiograms (ECG) signals recorded in ...

Home May 18, 2022
News | Wearables

May 4, 2022 – Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm ...

Home May 04, 2022
News | Wearables

April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG ...

Home April 12, 2022
News | Wearables
March 25, 2022 – Consumers are increasingly using smartwatches and other wearable devices to measure their heart rate ...
Home March 25, 2022
News | Wearables
March 1, 2022 – A new report says the wearable healthcare devices market is anticipated to grow at a CAGR of 13% from ...
Home March 01, 2022
News | Wearables

Chenyang Lu, a professor of computer science and engineering, is marrying Fitbits with machine learning to predict which ...

Home February 09, 2022
News | Wearables

January 7, 2022 — Abbott announced it is developing a new category of consumer biowearables called Lingo, which is being ...

Home January 07, 2022
News | Wearables

November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers ...

Home November 18, 2021
News | Wearables

November 1, 2021 — Health AI company, based in Cambridge, U.K., has launched a 30-second breathing test for ...

Home November 01, 2021
News | Wearables

October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for ...

Home October 15, 2021
Subscribe Now